anticancer antibodies (CSL/Patrys)

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug Nameanticancer antibodies (CSL/Patrys)
Drug Alias NamePAT-CSL1PAT-CSL4PAT-CSL3PAT-CSL2
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPatrys Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCsl LtdPatrys Ltd
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A